According to Xylem's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 47.9211. At the end of 2021 the company had a P/E ratio of 50.3.
Year | P/E ratio | Change |
---|---|---|
2021 | 50.3 | -29.69% |
2020 | 71.5 | 102.43% |
2019 | 35.3 | 61.92% |
2018 | 21.8 | -41.17% |
2017 | 37.1 | 8.53% |
2016 | 34.2 | 74.14% |
2015 | 19.6 | -6.1% |
2014 | 20.9 | -25.71% |
2013 | 28.1 | 63.57% |
2012 | 17.2 | 1.02% |
2011 | 17.0 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() Thermo Fisher Scientific TMO | 34.2 | -28.69% | ๐บ๐ธ USA |
![]() IDEX IEX | 26.9 | -43.85% | ๐บ๐ธ USA |
![]() Flowserve
FLS | 21.8 | -54.49% | ๐บ๐ธ USA |
![]() Franklin Electric
FELE | 21.5 | -55.19% | ๐บ๐ธ USA |
![]() Colfax Corporation CFX | 27.1 | -43.40% | ๐บ๐ธ USA |
![]() The Toro Company
TTC | 23.0 | -51.91% | ๐บ๐ธ USA |
![]() ITT ITT | 19.2 | -59.95% | ๐บ๐ธ USA |
![]() Graco GGG | 24.3 | -49.33% | ๐บ๐ธ USA |
![]() Gorman-Rupp GRC | 39.8 | -16.88% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.